Patents by Inventor Ruth M. Kramer

Ruth M. Kramer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human phospholipase A2 and related nucleic acid compounds
    Patent number: 6242206
    Abstract: The invention provides a novel phospholipase A2 enzyme, polynucleotides encoding such enzyme and methods for screening unknown compounds for anti-inflammatory activity mediated by the arachidonic acid cascade.
    Type: Grant
    Filed: February 7, 2000
    Date of Patent: June 5, 2001
    Assignee: Eli Lilly and Company
    Inventors: Xue-Chiou C. Choiu, Ruth M. Kramer, Richard T. Pickard, John D. Sharp, Beth A. Strifler
  • Human phospholipase A2 and related nucleic acid compounds
    Patent number: 6197569
    Abstract: The invention provides a novel phospholipase A2 enzyme, polynucleotides encoding such enzyme and methods for screening unknown compounds for anti-inflammatory activity mediated by the arachidonic add cascade.
    Type: Grant
    Filed: February 7, 2000
    Date of Patent: March 6, 2001
    Assignee: Eli Lilly and Company
    Inventors: Xue-Chiou C. Choiu, Ruth M. Kramer, Richard T. Pickard, John D. Sharp, Beth A. Strifler
  • Human phospholipase A.sub.2 and related nucleic acid compounds
    Patent number: 6025178
    Abstract: The invention provides a novel phospholipase A.sub.2 enzyme, polynucleotides encoding such enzyme and methods for screening unknown compounds for anti-inflammatory activity mediated by the arachidonic acid cascade.
    Type: Grant
    Filed: March 28, 1997
    Date of Patent: February 15, 2000
    Assignee: Eli Lilly and Company
    Inventors: Xue-Chiou C. Choiu, Ruth M. Kramer, Richard T. Pickard, John D. Sharp, Beth A. Strifler
  • Compounds, vectors and methods for expressing human, cytosolic phospholipase A.sub.2
    Patent number: 5328842
    Abstract: The invention includes recombinant DNA compounds, vectors and methods useful for expressing an exceptionally rare, human, cytosolic phospholipase A.sub.2 (cPLA.sub.2) enzyme. The invention also includes a method for screening compounds to identify inhibitors of cPLA.sub.2 which is believed to partake in several disease processes.
    Type: Grant
    Filed: April 12, 1993
    Date of Patent: July 12, 1994
    Assignee: Eli Lilly and Company
    Inventors: Xue-Chiou C. Chiou, JoAnn Hoskins, Ruth M. Kramer, John D. Sharp, Donald L. White